𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment

✍ Scribed by Sebastian A. Müller; Korbinian Holzapfel; Christof Seidl; Uwe Treiber; Bernd J. Krause; Reingard Senekowitsch-Schmidtke


Publisher
Springer
Year
2009
Tongue
English
Weight
230 KB
Volume
36
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Bicalutamide dosages used in the treatme
✍ Kolvenbag, Geert J.C.M.; Nash, Anthony 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

## BACKGROUND. Androgen deprivation is often used for the treatment of patients with prostate cancer. Androgen deprivation can be achieved by surgical castration or medical castration, with or without using an antiandrogen. Each of these treatments may be used alone, or an antiandrogen may be used

Bicalutamide (Casodex®) in the treatment
✍ Kolvenbag, Geert J.C.M.; Blackledge, George R.P.; Gotting-Smith, Karen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

BACKGROUND. Bicalutamide (Casodex) is a new nonsteroidal antiandrogen developed for use in patients with prostate cancer. The efficacy and tolerability of bicalutamide as monotherapy and as combination therapy for patients with advanced prostate cancer have been evaluated in randomized clinical tria

Pretreatment of docetaxel enhances TRAIL
✍ Jinsang Yoo; Sung-Soo Park; Yong J. Lee 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 1 views

## Abstract Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) is a promising cancer therapeutic agent because of its tumor selectivity. TRAIL is known to induce apoptosis in cancer cells but spare most normal cells. In this study, we examined whether treatment of docetaxel (DTX) can e